Analytical Data
-
Gene name
GNGT2
- Application
-
Alternative Names
GNGT2; GNG8; GNG9; GNGT8Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-T2; G gamma-C; G-gamma-8; G-gamma-9; Guanine nucleotide binding protein gamma transducing activity polypeptide 2
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O14610
-
Expression Region
1-69aa
-
AA Sequence
MAQDLSEKDLLKMEVEQLKKEVKNTRIPISKAGKEIKEYVEAQAGNDPFLKGIPEDKNPFKEKGGCLIS
-
Molecular Weight
33.33 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
GNGT2, a gene that encodes a member of the guanine nucleotide-binding protein family, has garnered significant interest in scientific research due to its pivotal role in signal transduction pathways. These pathways are essential for various cellular processes, including growth, differentiation, and apoptosis. Studies have shown that GNGT2 is involved in the modulation of intracellular signaling, particularly in the context of G-protein-coupled receptor (GPCR) activation. The role of GNGT2 in physiological and pathological conditions, such as cancer and cardiovascular diseases, underscores the necessity for a deeper understanding of its molecular mechanisms. Recombinant protein technology has emerged as a powerful tool to investigate GNGT2 function, enabling researchers to express and purify this protein for detailed structural and functional analyses. By utilizing techniques such as site-directed mutagenesis and surface plasmon resonance, scientists can elucidate the interactions between GNGT2 and its binding partners, paving the way for potential therapeutic applications. The ongoing research into GNGT2 recombination not only contributes to the basic understanding of G-protein signaling but also holds promise for the development of novel strategies to target diseases associated with dysregulated GNGT2 activity. Thus, the investigation of GNGT2 recombinant protein serves as a critical avenue for advancing our comprehension of cellular signaling dynamics and their implications in health and disease.
